CHRNA7 and Alzheimer disease: Furthermore, lovastatin can upregulate α7nAChR (nicotinic acetylcholine receptor) expression, decrease cholinesterase activity, and reduce αAPP accumulation, suggesting its potential neuroprotective role in AD treatment [77].